Addie Rerecich Case Study Answers

994 Words2 Pages

Addie Rerecich
1. She had fever, felt a pain in her hip, loss of sleep, the then pain spread to several parts of the body over the next few days her blood pressure of dropped significantly during the first day of her illness, she also had little infected boils all over her body. Doctors thought that Addie was infected with a virus. In the first hospital and pneumonia in the hospital which specialized in children’s care.
2. Addie may have become infected with the resistant staphylococcus bacteria in the playground while playing with her friends.
3. Addie acquired Stenotrophomonas bacterial infection in the hospital. She acquired it from the tubes of the lung bypass machine ECMO which doctors used to try and support her respiration after her …show more content…

Eighteen patients were consequently infected by KPC in the hospital and six died of it.
Antibiotic resistance and the Public Health
1. Alexander Fleming discovered penicillin in 1945.
2. Public health officials estimate that up to 50% of all antibiotics use in the U.S is either unnecessary or in appropriate.
3. It is more lucrative for drug companies to develop drugs for chronic illnesses as opposed to antibiotics because the chronic illness drugs will be far much cheaper to develop and will be sold for longer periods than antibiotic drugs which will need heavy investments to develop and be sold more sparingly over time.
4. The federal government doesn’t have a comprehensive plan to combat and coordinate antimicrobial resistance in the U.S as the secretary of Health and human services even turns down an interview to explain the actions of the government in relation to antimicrobial resistance.
5. Many countries in Europe collect data on the locations of antimicrobial resistance occurrences, the number of incidences , who uses antibiotics, and the health practitioners who may overusing the antibiotics so as to address the problem of anti-microbial resistance.
6. Approximately it costs one billion U.S dollars to introduce a new drug into the

Open Document